Laboratory of Cytogenetics and Molecular Diagnostics, Division of Cancer Research, Regional Cancer Centre, Medical College Post, Trivandrum, 695011, Kerala, India.
Laboratory of Cytogenetics and Molecular Diagnostics, Division of Cancer Research, Regional Cancer Centre, Medical College Post, Trivandrum, 695011, Kerala, India.
Biomed Pharmacother. 2017 Sep;93:1238-1245. doi: 10.1016/j.biopha.2017.07.035. Epub 2017 Jul 20.
DNA damaging agents are most common in chemotherapeutic molecules that act against cancer. However, cancer cells possess inherent biological features to overcome DNA damages by activating various distinct repair mechanisms and pathways. Importantly, various oncogenes, cancer stem cells (CSCs), hypoxic environment, transcription factors and bystander signaling that are activated in the cancer cells influence DNA repair, thereby effectively repairing the DNA damage. Repaired cancer cells often become more resistance to further therapy and results in disease recurrence. In this review, we summarize how the various signaling pathways in cancer cells regulates DNA repair and induce chemoresistance.
DNA 损伤剂在针对癌症的化疗分子中最为常见。然而,癌细胞通过激活各种不同的修复机制和途径来克服 DNA 损伤,具有内在的生物学特征。重要的是,在癌细胞中激活的各种癌基因、癌症干细胞 (CSCs)、缺氧环境、转录因子和旁观者信号会影响 DNA 修复,从而有效地修复 DNA 损伤。修复后的癌细胞往往对进一步的治疗更具抵抗力,导致疾病复发。在这篇综述中,我们总结了癌细胞中的各种信号通路如何调节 DNA 修复并诱导化疗耐药性。